191 related articles for article (PubMed ID: 31967328)
1. Esomeprazole fixed drug eruption.
Salloum A; Nasr D; Maalouf D
Contact Dermatitis; 2020 May; 82(5):334-335. PubMed ID: 31967328
[No Abstract] [Full Text] [Related]
2. Esomeprazole-induced ashy dermatosis-like drug eruptions.
Chang HC; Chang YS; Wang KH; Cheng T; Tsai HH
Australas J Dermatol; 2019 Aug; 60(3):e232-e233. PubMed ID: 30565221
[No Abstract] [Full Text] [Related]
3. A case report of fixed drug eruption caused by several drugs because of cross-reactivity and co-sensitization.
Sobrino-García M; Gómez-Cardeñosa A; Moreno-Rodilla E; Muñoz-Bellido FJ; Lázaro-Sastre M; Dávila I
Contact Dermatitis; 2019 Jan; 80(1):56-57. PubMed ID: 30246872
[No Abstract] [Full Text] [Related]
4. Nonpigmented fixed drug eruption induced by esomeprazole.
Morais P; Baudrier T; Mota A; Cunha AP; Cadinha S; Barros AM; Azevedo F
Cutan Ocul Toxicol; 2010 Sep; 29(3):217-20. PubMed ID: 20470240
[TBL] [Abstract][Full Text] [Related]
5. Sticky Palms Following Use of Proton-Pump Inhibitors.
Alkeraye S; Baclet Y; Delaporte E
JAMA Dermatol; 2016 Jun; 152(6):722-3. PubMed ID: 26962767
[No Abstract] [Full Text] [Related]
6. Cutaneous reactions to proton pump inhibitors: a case-control study.
Chularojanamontri L; Jiamton S; Manapajon A; Suvanasuthi S; Kulthanan K; Dhana N; Jongjarearnprasert K
J Drugs Dermatol; 2012 Oct; 11(10):e43-7. PubMed ID: 23134998
[TBL] [Abstract][Full Text] [Related]
7. Widespread Scaly Eruption in a Patient With Multiple Comorbidities.
Jones EK; Mingioni N; Lee JB
JAMA; 2015 Oct; 314(16):1740-1. PubMed ID: 26505598
[No Abstract] [Full Text] [Related]
8. [Study of cross reactivity between proton pump inhibitors].
Hammami S; Affes H; Ksouda K; Feki M; Sahnoun Z; Zeghal KM
Therapie; 2013; 68(6):361-8. PubMed ID: 24356187
[TBL] [Abstract][Full Text] [Related]
9. Lichenoid drug eruption.
Brauer J; Votava HJ; Meehan S; Soter NA
Dermatol Online J; 2009 Aug; 15(8):13. PubMed ID: 19891921
[TBL] [Abstract][Full Text] [Related]
10. Predisposition to multi-drug hypersensitivity after administration of mogamulizumab.
Miyagawa F; Yamamoto S; Miyao M; Nishikawa M; Ogawa K; Asada H
Eur J Dermatol; 2018 Aug; 28(4):526-528. PubMed ID: 29952299
[No Abstract] [Full Text] [Related]
11. Fatal outcome of DRESS syndrome associated with esomeprazole.
Zaïem A; Charfi O; Badri T; Elaidli S
Indian J Dermatol Venereol Leprol; 2015; 81(4):407-8. PubMed ID: 26087082
[No Abstract] [Full Text] [Related]
12. Esomeprazole induced galactorrhea: a novel side effect.
Pipaliya N; Solanke D; Rathi C; Patel R; Ingle M; Sawant P
Clin J Gastroenterol; 2016 Feb; 9(1):13-6. PubMed ID: 26661629
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism.
Swaminathan K
Indian J Pharmacol; 2015; 47(3):330-1. PubMed ID: 26069375
[TBL] [Abstract][Full Text] [Related]
14. Letter: proton pump inhibitors, hypergastrinaemia and the risk of gastric neoplasia.
Waldum HL; Hauso Ø; Fossmark R
Aliment Pharmacol Ther; 2015 Aug; 42(3):389. PubMed ID: 26147114
[No Abstract] [Full Text] [Related]
15. [Lupus erythematosus and proto-pump inhibitors].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2014 Mar; 141(3):252-3. PubMed ID: 24635967
[No Abstract] [Full Text] [Related]
16. Esomeprazole-induced irritability.
Celikbilek A; Celikbilek M; Akyol L; Pirti I
Acta Neurol Belg; 2014 Sep; 114(3):251-2. PubMed ID: 23975557
[No Abstract] [Full Text] [Related]
17. Skin testing for hypersensitivity and cross-reactivity between proton pump inhibitors.
Li PH
Hong Kong Med J; 2020 Oct; 26(5):450.e1-450.e2. PubMed ID: 33089794
[No Abstract] [Full Text] [Related]
18. [Rhabdomyolysis associated with long-term treatment of esomeprazole].
Nishikawa J; Hosokawa A; Fuchino M; Takatori S; Iwamoto M; Kashii Y; Bando T; Shimizu T; Minemura M; Sugiyama T
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(3):299-304. PubMed ID: 29526982
[TBL] [Abstract][Full Text] [Related]
19. Esomeprazole-induced rhabdomyolysis in a patient with heart failure.
Tröger U; Reiche I; Jepsen MS; Huth C; Bode-Böger SM
Intensive Care Med; 2010 Jul; 36(7):1278-9. PubMed ID: 20229039
[No Abstract] [Full Text] [Related]
20. Proton pump inhibitors and subacute cutaneous lupus erythematosus: an under-recognized phenomenon?
Cookson H; Walsh S
Br J Dermatol; 2014 Feb; 170(2):235. PubMed ID: 24547716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
